Euglena Co., Ltd. (TYO:2931)

Sage Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Sep 30, 2021
Market Capitalization	66,423	56,602	81,640	110,823	78,910	95,932
Market Cap Growth	-15.42%	-30.67%	-26.33%	40.44%	-17.74%	17.10%
Enterprise Value	73,511	63,259	91,824	123,059	93,404	111,148
Last Close Price	487.00	415.00	697.00	980.00	710.00	874.00
Forward PE	240.49	-	-	-	-	-
PS Ratio	1.37	1.19	1.76	2.50	2.59	4.12
PB Ratio	2.10	1.76	4.04	5.73	3.83	4.32
P/FCF Ratio	-	25.43	236.64	186.26	83.59	70.96
P/OCF Ratio	-	21.40	124.07	119.94	71.58	63.91
EV/Sales Ratio	1.52	1.33	1.98	2.77	3.06	4.77
EV/EBITDA Ratio	16.65	16.22	60.97	-	-	-
EV/EBIT Ratio	111.55	209.47	-	-	-	-
EV/FCF Ratio	-	28.42	266.16	206.82	98.95	82.21
Debt / Equity Ratio	0.80	0.81	1.24	1.15	1.21	1.16
Debt / EBITDA Ratio	5.80	6.65	16.65	-	-	-
Debt / FCF Ratio	-	11.64	72.67	37.35	26.39	19.07
Asset Turnover	0.68	0.72	0.80	0.75	-	0.59
Inventory Turnover	3.48	3.91	3.54	2.42	-	1.59
Quick Ratio	1.97	1.94	1.59	1.12	1.25	1.35
Current Ratio	2.52	2.41	1.99	1.60	1.92	2.24
Return on Equity (ROE)	-1.85%	-0.89%	-13.43%	-13.42%	-	-20.44%
Return on Assets (ROA)	0.54%	0.28%	-1.57%	-3.74%	-	-6.24%
Return on Capital (ROIC)	0.67%	0.36%	-2.11%	-5.07%	-	-8.11%
Return on Capital Employed (ROCE)	1.00%	0.50%	-	-	-	-
Earnings Yield	-2.03%	-1.15%	-3.25%	-2.41%	-5.93%	-2.53%
FCF Yield	-	3.93%	0.42%	0.54%	1.20%	1.41%
Buyback Yield / Dilution	-13.56%	-15.22%	-3.96%	-6.69%	-4.26%	-8.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.